EP Patent

EP0814080A1 — Squalene synthetase inhibitors

Assigned to Pfizer Inc · Expires 1997-12-29 · 28y expired

What this patent protects

This invention relates to certain benzoxazepinones and benzothiazepinones of Formula I, useful as hypocholesterolemic agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, Alzheimer's agents or anti-acne agents.

USPTO Abstract

This invention relates to certain benzoxazepinones and benzothiazepinones of Formula I, useful as hypocholesterolemic agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, Alzheimer's agents or anti-acne agents.

Drugs covered by this patent

Patent Metadata

Patent number
EP0814080A1
Jurisdiction
EP
Classification
—
Expires
1997-12-29
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.